← Leaderboards
Nina H. Lin
Massachusetts General Hospital
$7,153,013
Attributed
$11,709,139
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2011–22$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$11,709,139 · 4
By mechanism
R01$7,827,809 · 2
R61$3,206,561 · 1
K08$674,769 · 1
Top collaborators
- Suryaram Gummuluru5 shared
- Manish Sagar5 shared
- Athe M. Tsibris3 shared
- Avrum E Spira1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jonathan P Winickoff$16,869,989
- Athe M. Tsibris$17,945,517
- Read Pukkila-Worley$9,819,564
- Zev David Schuman Olivier$4,945,522
- Douglas Levy$10,993,760
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingAntiretroviral TherapyCellsPathogenesisBiologicalGenetic TranscriptionHiv InfectionsImmuneViremiaVirusProductionMediatingResidual StateBloodInflammatoryGene ExpressionAge RelatedGenesInsightAutologousCytokineInflammationAutomobile DrivingImmune Activation
Grant awards (19)
Persistent HIV expression induced type I IFN responses and inflammaging$771,666
R01 · FY2022 · AG
Impact of smoking and its cessation on systemic and airway immune activation$798,550
R01 · FY2021 · DA · contact PI
Persistent HIV expression induced type I IFN responses and inflammaging$778,565
R01 · FY2021 · AG
The effects of opioid use on HIV-1 reservoir dynamics$1,066,790
R61 · FY2020 · DA
Impact of smoking and its cessation on systemic and airway immune activation$800,817
R01 · FY2020 · DA · contact PI
Persistent HIV expression induced type I IFN responses and inflammaging$742,299
R01 · FY2020 · AG
The effects of opioid use on HIV-1 reservoir dynamics$1,057,122
R61 · FY2019 · DA
Impact of smoking and its cessation on systemic and airway immune activation$799,886
R01 · FY2019 · DA · contact PI
Persistent HIV expression induced type I IFN responses and inflammaging$737,535
R01 · FY2019 · AG
The effects of opioid use on HIV-1 reservoir dynamics$1,082,649
R61 · FY2018 · DA
Persistent HIV expression induced type I IFN responses and inflammaging$778,455
R01 · FY2018 · AG
Impact of smoking and its cessation on systemic and airway immune activation$792,371
R01 · FY2017 · DA · contact PI
Impact of smoking and its cessation on systemic and airway immune activation$827,665
R01 · FY2016 · DA · contact PI
Analysis of properties of HIV-1 subtype C envelope glycoprotein$129,683
K08 · FY2015 · AI · contact PI
Analysis of properties of HIV-1 subtype C envelope glycoprotein$121,126
K08 · FY2014 · AI · contact PI
Analysis of properties of HIV-1 subtype C envelope glycoprotein$11,016
K08 · FY2014 · AI · contact PI
Analysis of properties of HIV-1 subtype C envelope glycoprotein$137,648
K08 · FY2013 · AI · contact PI
Analysis of properties of HIV-1 subtype C envelope glycoprotein$137,648
K08 · FY2012 · AI · contact PI
Analysis of properties of HIV-1 subtype C envelope glycoprotein$137,648
K08 · FY2011 · AI · contact PI